1.

The Competition Commission of India (CCI) approved the proposed acquisition of four drug brands of GlaxoSmithKline by Corona Remedies. Which one of the following brands of GlaxoSmithKline will not be acquired by Corona Remedies?

A. Dilo-BM
B. Dilo-DX
C. Stelbid
D. Coreg CR
Answer» E.


Discussion

No Comment Found